Subject(s)
Chikungunya Fever , Chikungunya virus , Disease Outbreaks , Viral Vaccines , Humans , Antibodies, Neutralizing/immunology , Antibodies, Viral/immunology , Chikungunya Fever/epidemiology , Chikungunya Fever/immunology , Chikungunya Fever/prevention & control , Paraguay/epidemiology , Vaccines , Viral Vaccines/adverse effects , Viral Vaccines/immunology , Viral Vaccines/therapeutic use , Disease Outbreaks/prevention & control , Disease Outbreaks/statistics & numerical dataABSTRACT
Introduction: As of October 26, 2022, only 9% of children in the United States aged 6 months to 4 years have received at least one dose of COVID-19 vaccine despite FDA approval since June 17, 2022. Rates are better yet still low for children aged 5 to 11 years as nearly 30% were fully vaccinated as of August 23, 2022. Vaccine hesitancy among adults is one of the major factors affecting low vaccine uptake rates in children against COVID-19, yet most studies examining vaccine hesitancy have targeted school-age and adolescent children. Methods: With the aim of assessing the willingness to recommend the COVID-19 vaccination to children under 5 years compared to children 5 to 12 years of age, a county-wide survey was conducted between January 11 and March 7, 2022, among adults on the United States-Mexico border. Results: Among the 765 responses, 72.5% were female and 42.3% were Latinx. The most significant factor associated with likelihood to recommend the COVID-19 vaccine to children less than 5 years and 5-12 years of age was adult vaccination status. Ordinal logistic regression also indicated that ethnicity, primary language, being a parent, previous COVID-19 infection, and concern about getting COVID-19 in the future were significantly associated with likelihood of COVID-19 vaccine recommendation to children < 5 years and 5-12 years old. Discussion: This study found high consistency among respondents in their willingness to vaccinate children aged < 5 years compared with children aged 5-12 years. Our findings support public health strategies that target adult vaccinations as an avenue to improve childhood vaccinations for young children.
Subject(s)
COVID-19 Vaccines , COVID-19 , Adolescent , Adult , Humans , Child , Female , Child, Preschool , Male , COVID-19/epidemiology , COVID-19/prevention & control , Mexico/epidemiology , Vaccination Hesitancy , EthnicitySubject(s)
Child Behavior Disorders/therapy , Child Guidance/education , Internship and Residency , Mental Disorders/therapy , Pediatrics/education , Adolescent , Behavioral Medicine/education , Child , Child Behavior Disorders/diagnosis , Clinical Competence , Curriculum , Humans , Interdisciplinary Communication , Mental Disorders/diagnosis , Mental Health , United StatesABSTRACT
The editorial office and authors have requested that this article be withdrawn due to additional information discovered regarding the patient in which the article was written. The full Elsevier Policy on Article Withdrawal can be found at http://www.elsevier.com/locate/withdrawalpolicy.